DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

Ladenburg Thalmann Initiates Coverage On ArTara Therapeutics with Buy Rating, Announces $45 Price Target

Ladenburg Thalmann analyst Matthew Kaplan initiates coverage on ArTara Therapeutics (NASDAQ:TARA) with a Buy rating and a $45 price target.

Benzinga · 01/22/2020 12:29

Ladenburg Thalmann analyst Matthew Kaplan initiates coverage on ArTara Therapeutics (NASDAQ:TARA) with a Buy rating and a $45 price target.